January 9, 2025

Applications of TCR-epitope prediction models: T-cell based therapies in oncology

Are you a researcher working on T cell–based therapies in oncology and want maximise the value of your T-cell Receptor (TCR) repertoires? Then we’re pleased to invite you to an upcoming webinar, Applications of TCR-epitope prediction models: T-cell based therapies in oncology

‍

🗓️ Webinar Details:

Date: Thursday, 30 January 2025

Time: 16:00 CEST | 10:00 EDT | 07:00 PDT

‍

During the webinar we will explore multiple use cases that demonstrate the value of epitope-specific TCR repertoire analysis in clinical oncology applications derived from clinical data. Discover how it can be used to learn more about the composition of your T-cell products as part of the quality control process. Or how it can be used as an immunomonitoring tool to evaluate efficacy.

‍

Why Attend?

✅ Maximise the value of your TCR repertoires

✅ Learn about the state-of-the-art of epitope-specific TCR repertoire analysis

‍

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!

Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

July 29, 2024

Introducing a paradigm shift in TCR-based diagnostics

Each infection, vaccine, cancer cell or autoimmune disease can leave a telltale signature in your collection of T cells, the TCR repertoire. That is a consequence of how your immune system recognises and memorises intruders.

July 29, 2024

Launching the ImmuneWatch DETECT Early Access Program

Are you ready to change the way you interpret your TCR sequencing data? We’re thrilled to announce the launch of our ImmuneWatch DETECT Early Access Program – a unique opportunity for innovators that are using TCR sequencing.